- Clear All
- Remove thePharmacologyfilter Pharmacology
- Remove theImmunologyfilter Immunology
- Remove the2020filter 2020
- Remove the2016filter 2016
- Remove theNational legislation & regulationfilter National legislation & regulation
- Remove theProduction medicinefilter Production medicine
- Remove theOne Healthfilter One Health
JAVMA news
Old, new deputy CEO see AVMA moving profession forward
What kept Dr. Elizabeth A. Curry-Galvin on the staff of the AVMA for two decades?
JAVMA news
Q&A with Dr. Elizabeth A. Curry-Galvin
Dr. Elizabeth A. Curry-Galvin, outgoing deputy chief executive officer of the AVMA, answers questions from JAVMA News.
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
JAVMA news
AVMA advocates against prescription mandate bill
In April, AVMA Board of Directors chair Dr. John de Jong testified before a House subcommittee about the Fairness to Pet Owners Act (HR 3174/S 1200),
JAVMA news
The slow rise of generic animal drugs
In human medicine, generic drugs accounted for 88 percent of prescriptions dispensed in the United States as of 2014.
JAVMA news
FDA describes legal limits of drug compounding
Agency says few uses allowed for raw active ingredients
JAVMA news
Guiding drug use, changing practices
When veterinarians are considering how to treat infections, AVMA officials hope a new report will help bring a panel of experts into the room. And…
blog
AVMA prepares response to FDA draft compounding guidance
Based on feedback from member veterinarians and other stakeholders, the AVMA has compiled a list of key points to share with the FDA in our formal…
JAVMA news
The hype and hope of veterinary cannabis
A range of issues were covered at the first AVMA Cannabis Symposium, from regulatory and toxicological concerns to the drug’s potential as a…